ES2077698T3 - Agente terapeutico para la gangrena diabetica. - Google Patents

Agente terapeutico para la gangrena diabetica.

Info

Publication number
ES2077698T3
ES2077698T3 ES91102606T ES91102606T ES2077698T3 ES 2077698 T3 ES2077698 T3 ES 2077698T3 ES 91102606 T ES91102606 T ES 91102606T ES 91102606 T ES91102606 T ES 91102606T ES 2077698 T3 ES2077698 T3 ES 2077698T3
Authority
ES
Spain
Prior art keywords
diabetic
gangrena
therapeutic agent
agent
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91102606T
Other languages
English (en)
Inventor
Masahiko Shikano
Satoshi Tanaka
Masao Ikdea
Hiroshi Nin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan Ltd filed Critical Hoechst Japan Ltd
Application granted granted Critical
Publication of ES2077698T3 publication Critical patent/ES2077698T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

SE DESCRIBE UN AGENTE PARA LA TERAPIA DE LA GANGRENA DIABETICA QUE CONTIENE AL FACTOR XIII DE COAGULACION DE LA SANGRE COMO INGREDIENTE ACTIVO.
ES91102606T 1990-02-20 1991-02-22 Agente terapeutico para la gangrena diabetica. Expired - Lifetime ES2077698T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2037284A JPH03240738A (ja) 1990-02-20 1990-02-20 糖尿病性壊疽治療剤
EP91102606A EP0499679B1 (en) 1990-02-20 1991-02-22 Therapeutic agent for diabetic gangrene

Publications (1)

Publication Number Publication Date
ES2077698T3 true ES2077698T3 (es) 1995-12-01

Family

ID=40202967

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91102606T Expired - Lifetime ES2077698T3 (es) 1990-02-20 1991-02-22 Agente terapeutico para la gangrena diabetica.

Country Status (13)

Country Link
US (1) US5164373A (es)
EP (1) EP0499679B1 (es)
JP (1) JPH03240738A (es)
KR (1) KR0184008B1 (es)
AT (1) ATE128358T1 (es)
AU (1) AU647078B2 (es)
CA (1) CA2036592C (es)
DE (1) DE69113437T2 (es)
DK (1) DK0499679T3 (es)
ES (1) ES2077698T3 (es)
GR (1) GR3017672T3 (es)
IE (1) IE69393B1 (es)
PT (1) PT96828B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3337488B2 (ja) * 1992-03-06 2002-10-21 アベンティス ファーマ株式会社 切迫流産治療剤
DE19508192A1 (de) * 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung
CN1668317B (zh) * 2002-05-09 2010-04-28 医学基因公司 用于处理伤口的含血浆或血清的药物组合物
KR101897534B1 (ko) * 2008-04-21 2018-09-12 노보 노르디스크 헬스 케어 악티엔게젤샤프트 건조한 트랜스글루타미나제 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931399A (en) * 1970-12-22 1976-01-06 Behringwerke Aktiengesellschaft Process for isolating a fibrin-stabilizing factor
US3904751A (en) * 1970-12-22 1975-09-09 Behringwerke Ag Process for isolating a fibrin stabilizing factor from human placenta
JPS6029687B2 (ja) * 1978-11-07 1985-07-12 株式会社ミドリ十字 ヒト胎盤由来血液凝固第１０３因子の濃縮液の製造方法
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
DE3419581A1 (de) * 1984-05-25 1985-11-28 Behringwerke Ag, 3550 Marburg Verfahren zur gewinnung einer faktor xiii-praeparation sowie ihre verwendung
JPS63196520A (ja) * 1987-02-09 1988-08-15 Hoechst Japan Kk 潰瘍性大腸炎治療剤
US4904751A (en) * 1987-12-21 1990-02-27 Texaco Chemical Company N,N'-dialkyl substituted polyoxyalklene amines as curing agents for blocked isocyanates
AT397203B (de) * 1988-05-31 1994-02-25 Immuno Ag Gewebeklebstoff
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva

Also Published As

Publication number Publication date
CA2036592A1 (en) 1991-08-21
DK0499679T3 (da) 1996-02-05
JPH03240738A (ja) 1991-10-28
AU647078B2 (en) 1994-03-17
US5164373A (en) 1992-11-17
KR0184008B1 (ko) 1999-05-01
GR3017672T3 (en) 1996-01-31
JPH0561253B2 (es) 1993-09-06
EP0499679A1 (en) 1992-08-26
PT96828A (pt) 1991-11-29
PT96828B (pt) 1998-07-31
CA2036592C (en) 2004-04-06
KR910021244A (ko) 1991-12-20
AU7117891A (en) 1991-08-22
ATE128358T1 (de) 1995-10-15
IE69393B1 (en) 1996-09-18
IE910565A1 (en) 1991-08-28
DE69113437T2 (de) 1996-04-11
EP0499679B1 (en) 1995-09-27
DE69113437D1 (de) 1995-11-02

Similar Documents

Publication Publication Date Title
DE3382458D1 (de) Haarwuchsmittel.
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
ES2079176T3 (es) Agente de contraste para ecografia.
NO171365C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
ES2055120T3 (es) Procedimiento de estabilizacion de las soluciones de albumina humana y solucion obtenida.
DE69327432T2 (de) Heilmittel für wunden und hämorrhoiden
ATE62414T1 (de) Mittel zur behandlung von herzerkrankungen.
DK261490D0 (da) New pharmaceutical compound
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
ATE97813T1 (de) Mittel zur kontrolle von thrombenbildungen.
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
ES2059588T3 (es) Factor xiii para la prevencion de una hemorragia intraventricular.
ES2077698T3 (es) Agente terapeutico para la gangrena diabetica.
KR930019224A (ko) 유산 위험 치료제
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
NO156900B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater.
ATE56147T1 (de) T-pa enthaltende medizinische zubereitung und deren verwendung.
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
DE3877499D1 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
SE8704093L (sv) Terapeutiska medel och anvendning derav
KR890000089A (ko) 신장 질환 치료제

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 499679

Country of ref document: ES